On Thursday, May 14, 2026, the NIDA IRP Clinical Program welcomed representatives from the Office of the Lieutenant Governor. Aruna Miller and her staff received a tour of our facilities and learned about the cutting edge research we are conducting in the field of addiction medicine.
Hot Off the Press
Cocaine chemogenetics blunts drug-seeking by synthetic physiology
Hot Off the Press – March 9, 2026 Published in Nature by Juan Gomez and Michael Michaelides et al. of the NIDA IRP Biobehavioral Imaging and Molecular Neuropsychopharmacology Section. Summary Our research team is pleased to announce the publication of our latest study in Nature, introducing a transformative synthetic biology platform designed to study and… [Read More]
Reviews To Read
Prospects of GLP-1 Therapies for Addiction and Mental Health Comorbidities-Quo Vadis?: A Review
Reviews To Read – February 2026 Published in JAMA Psychiatry by Mehdi Farokhnia and Lorenzo Leggio of the NIDA IRP Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section. New medicines that mimic a natural gut hormone called GLP-1 have already changed how clinicians treat type 2 diabetes, obesity and related cardiometabolic consequences. Because some of the same brain… [Read More]
Featured Papers
A ketogenic diet reduces hepatic alcohol metabolism and alcohol consumption in rats
Featured Paper of the Month – August 2026
Published in Neuropsychopharmacology by Sophie Elvig, Adrienne McGinn, and Leandro Vendruscolo, et al. of the NIDA/NIAAA Stress and Addiction Neuroscience Unit.
Findings from this study suggest that a ketogenic diet (a high-fat, low-carbohydrate diet) changes the way the body processes alcohol.
